For a few years, the second seasonal COVID-19 spike has been accompanied by rising cases of seasonal flu and RSV in what health officials called a “tripledemic.” Whooping cough and walking pneumonia ...

The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

The Centers for Disease Control and Prevention (CDC) recently warned that respiratory syncytial virus (RSV) and mycoplasma pneumonia, or “walking pneumonia,” are on the rise among very young children.

Coughing, sneezing, and high temperature are common signs of a cold. While these may look harmless, they can also be symptoms ...

Children are experiencing the largest rise in this mild respiratory infection, characterized by a lingering cough.

Researchers sought to determine if the RSV vaccine leads to better health outcomes among older adults with IBD.

RSV season is upon us, which means thousands of children under five years of age and hundreds of thousands of adults will be ...

Often people with walking pneumonia recover on their own ... Cases of COVID-19, influenza and respiratory syncytial virus ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...

recently warned that respiratory syncytial virus (RSV) and mycoplasma pneumonia, or “walking pneumonia,” are on the rise among very young children. Rates are higher than in recent years ...